Ingrid VanderElst advised Nordion Canada Inc. on regulatory and intellectual property issues associated with the negotiation and drafting of agreements with General Atomics and the University of Missouri Research Reactor Center to establish a new, reliable supply of medical isotopes to serve millions of patients globally.